Skip to main content

Table 8 Antibiotic Susceptibility patterns of isolates

From: Prevalence, antimicrobial susceptibility pattern and associated risk factors for urinary tract infections in pregnant women attending ANC in some integrated health centers in the Buea Health District

Ā 

S

n

(%)

I

n

(%)

R

n

(%)

S

n

(%)

I

n

(%)

R

n

(%)

S

n

(%)

I

n

(%)

R

n

(%)

S

n

(%)

I

n

(%)

R

n

(%)

S

n

(%)

I

n

(%)

R

n

(%)

Ā 

K

AM

CTX

CRO

C

E. coli

10

(26.3)

3

(7.9)

25

(65.8)

13

(26.3)

15

(42.1)

10

(31.6)

0

(0)

0

(0)

38

(100)

0

(0)

0

(0)

38

(100)

5

(13.2)

0

(0)

33

(86.8)

Enterobacter

3

(100)

0

(0)

0

(0)

0

(0)

0

(0)

3

(100)

0

(0)

0

(0)

3

(100)

0

(0)

0

(0)

3

(100)

0

(0)

0

(0)

3

(100)

Klebsiella pneumoniae

0

(0)

10

(58.8)

7

(41.2)

12

(70.6)

5

(29.4)

0

(0)

17

(100)

0

(0)

0

(0)

17

(100)

0

(0)

0

(0)

0

(0)

17

(100)

0

(0)

Proteus vulgaris

2

(28.6)

0

(0)

5

(71.4)

2

(28.6)

5

(71.4)

0

(0)

0

(0)

0

(0)

7

(100)

0

(0)

5

(71.4)

2

(28.6)

3

(42.9)

1

(14.2)

3

(42.9)

Pseudomonas aeruginosa

0

(0)

0

(0)

5

(100)

0

(0)

0

(0)

5

(100)

5

(100)

0

(0)

0

(0)

0

(0)

0

(0)

5

(100)

0

(0)

3

(60)

2

(40)

Staphylococcus aureus

8

(100)

0

(0)

0

(0)

0

(0)

0

(0)

8

(100)

0

(0)

0

(0)

8

(100)

0

(0)

0

(0)

8

(100)

2

(20)

0

(0)

6

(80)

Total

23

(29.5)

15

(16.7)

42

(53.8)

27

(34.6)

25

(32.1)

26

(33.3)

12

(28.2)

0

(0)

56

(71.8)

17

(21.8)

5

(6.4)

56

(71.8)

10

(12.8)

21

(26.9)

47

(60.3)

Ā 

CIP

CN

TE

SXT

Ā Ā Ā 

E. coli

30

(78.9)

5

(13.2)

3

(7.9)

15

(39.5)

0

(0)

23

(60.5)

5

(13.6)

5

(13.6)

28

(73.7)

3

(7.9)

0

(0)

35

(92.1)

Ā Ā Ā 

Enterobacter

0

(0)

3

(100)

0

(0)

3

(100)

0

(0)

0

(0)

0

(0)

0

(0)

3

(100)

3

(100)

0

(0)

0

(0)

Ā Ā Ā 

Klebsiella pneumoniae

17

(100)

0

(0)

0

(0)

17

(100)

0

(0)

0

(0)

0

(0)

7

(41.2)

10

(58.8)

0

(0)

0

(0)

17

(100)

Ā Ā Ā 

Proteus vulgaris

5

(71.4)

2

(28.6)

0

(0)

7

(100)

0

(0)

0

(0)

0

(0)

0

(0)

7

(100)

2

(28.6)

5

(21.4)

0

(0)

Ā Ā Ā 

Pseudomonas aeruginosa

2

(100)

0

(0)

0

(0)

5

(100)

0

(0)

0

(0)

5

(100)

0

(0)

0

(0)

0

(0)

5

(100)

0

(0)

Ā Ā Ā 

Staphylococcus aureus

2

(22)

3

(37.5)

3

(37.5)

8

(100)

0

(0)

0

(0)

5

(62.5)

0

(0)

3

(37.5)

3

(37.5)

0

(0)

5

(62.5)

Ā Ā Ā 

Total

59

(75.6)

13

(18.7)

6

(7.7)

55

(70.5)

0

(0)

23

(29.5)

15

(19.2)

12

(15.4)

51

(65.4)

11

(14.1)

10

(12.8)

57

(73.1)

Ā Ā Ā 
  1. CN Gentamycin (20ug), CIP Ciprofloxacin (5ug), SXT Trimethoprim (1.25ug) and sulphamethoxazole (23.75ug), K Kanamycin (30ug), C chloramphenicol (5ug), TE Tetracycline (30ug), CRO Ceftriaxone (30ug), CTX Cefatoxime (30ug) and AM Ampicillin (10ā€‰mg). S Sensitive, I Intermediate, R Resistant